QDEL QuidelOrtho Corporation

  1. Stocks
  2. Healthcare
  3. NASDAQ: QDEL

Price (delayed)

$10.34

Market cap

$709.07M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$15.39

Enterprise value

$3.63B

?
Relative Growth: Rel. Growth: 13
Relative Strength: Rel. Strength: 8
Relative Valuation: Rel. Valuation: 37
Relative Profitability: Rel. Profitability: 17

With expertise spanning clinical chemistry, immunoassay, immunohematology and molecular testing, QuidelOrtho Corporation is a leading global provider of diagnostic solutions, dedicated to advancing fast, accurate and reliable results that help ...

Highlights
The net income has dropped by 125% year-on-year but it rose by 13% since the previous quarter
The company's EPS has shrunk by 124% YoY but it rose by 14% QoQ
The equity has contracted by 36% YoY and by 4.1% from the previous quarter
QDEL's debt is up by 10% YoY and by 7% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.quidel.com
Peers: BDX TMO OSUR DHR

Key stats

What are the main financial stats of QDEL

QDEL stock price

How has the QuidelOrtho stock price performed over time
Intraday
-5.48%
1 week
-3.99%
1 month
-29.85%
1 year
-62.32%
YTD
-63.8%
QTD
-40.96%

Financial performance

How have QuidelOrtho's revenue and profit performed over time
Revenue
$2.67B
Gross profit
$1.19B
Operating income
-$824.7M
Net income
-$1.05B
Gross margin
44.6%
Net margin
-39.2%
QDEL's net margin has plunged by 131% YoY but it is up by 14% from the previous quarter
The net income has dropped by 125% year-on-year but it rose by 13% since the previous quarter
QuidelOrtho's operating margin has increased by 17% from the previous quarter
QuidelOrtho's operating income has increased by 16% from the previous quarter

Price vs fundamentals

How does QDEL's price correlate with its fundamentals

Growth

What is QuidelOrtho's growth rate over time

Valuation

What is QuidelOrtho stock price valuation
QDEL P/E details
P/E
N/A
P/B
0.4
P/S
0.26
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.36
The company's EPS has shrunk by 124% YoY but it rose by 14% QoQ
The stock's price to book (P/B) is 65% less than its 5-year quarterly average of 1.2 and 48% less than its last 4 quarters average of 0.8
The equity has contracted by 36% YoY and by 4.1% from the previous quarter
QDEL's P/S is 80% below its 5-year quarterly average of 1.4 and 44% below its last 4 quarters average of 0.5
QDEL's revenue is down by 2.5% year-on-year

Efficiency

How efficient is QuidelOrtho business performance
QDEL's return on assets has dropped by 156% year-on-year but it is up by 11% since the previous quarter
QDEL's return on invested capital is up by 18% since the previous quarter
The company's return on sales rose by 17% QoQ

Dividends

What is QDEL's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for QDEL.

Financial health

How did QuidelOrtho financials performed over time
QDEL's total assets is 45% greater than its total liabilities
QDEL's quick ratio is up by 30% YoY but it is down by 8% from the previous quarter
The current ratio has increased by 24% YoY but it has decreased by 2.8% from the previous quarter
QDEL's debt is 71% more than its equity
The debt to equity has surged by 73% year-on-year and by 11% since the previous quarter
The equity has contracted by 36% YoY and by 4.1% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.